Skip to main content


Figure 1 | Journal of Pharmaceutical Policy and Practice

Figure 1

From: Contribution of antimicrobial stewardship programs to reduction of antimicrobial therapy costs in community hospital with 429 Beds --before-after comparative two-year trial in Japan

Figure 1

Antimicrobial stewardship programs flowchart. *Hospitalized patients: High care, internal medicine, surgery, orthopedics, cerebral surgery, ophthalmology, obstetrics and gynecology, otolaryngology and oral surgery units. Antimicrobial use: used Glycopeptides or Carbapenems used 3,4-Generation Cephalosporins or Quinolones for 14 days or more. Pathogenic microorganisms: Positive blood cultures, Methicillin-resistant Staphylococcus aureus, Extended spectrum beta-lactamase-producing organisms, Acinetobacter baumannii, Pseudomonas aeruginosa resistant to at least one among Carbapenems, Quinolones or Aminoglycosides §Team: a team comprised of medical doctors, pharmacists and microbiology technologists. The team then provided recommendations based on the supplemental elements to primary physicians who prescribed injectable antimicrobials. Other: recommendations for alternate agents and blood cultres.

Back to article page